正在加载公司
Just reported
From Davita's results release of 2026年10月29日; its quarterly report has since been filed.
Actual
US$3.58B
+4.6% y/y
+0.7% q/q
Guided
—
No guide given
Actual
US$3.40
+67% y/y
-15% q/q
Guided
—
No guide given
Actual
US$499.3M
-1.3% y/y
-14% q/q
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Davita is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.US$22.8BA+
EHCEncompass Health CorporationUS$13.8BA+
ENSGEnsign Group, Inc.US$10.9BA
PACSPACS Group, Inc.US$7.6BA
CONConcentra Group Holdings Parent, Inc.US$5.4BARose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026年10月21日CBGraded C, now B
MCKMckesson Corporation2026年11月4日BAGraded B, now A
CVSCVS Health Corp2026年11月4日BAGraded B, now A
EWEdwards Lifesciences Corporation2026年11月4日BAGraded B, now A
BIIBBiogen Inc.2026年10月28日BAGraded B, now A基于 Davita Inc. 自己向美国证券交易委员会（SEC）提交的申报文件。数字如实呈报，每股历史已重述到今天的股数口径。 这是对一门生意的描述——不是投资建议，也不是买卖任何证券的推荐。
Grade C
价格下方的色带显示每个日期的评级，仅依据当时已公开的文件计算。
显示 Davita Inc. 评级历史 32 个季度中的 2 个。 其余 30 个可回溯到 2019年2月。
